Výsledky vyhľadávania - "Multicenter Studies as Topic statistics & numerical data"

  • Zobrazené výsledky 1 - 19 z 19
Upresniť hľadanie
  1. 1
  2. 2

    Zdroj: van Maurik, I S, Vos, S J, Bos, I, Bouwman, F H, Teunissen, C E, Scheltens, P, Barkhof, F, Frolich, L, Kornhuber, J, Wiltfang, J, Maier, W, Peters, O, Rüther, E, Nobili, F, Frisoni, G B, Spiru, L, Freund-Levi, Y, Wallin, A K, Hampel, H, Soininen, H, Tsolaki, M, Verhey, F, Kłoszewska, I, Mecocci, P, Vellas, B, Lovestone, S, Galluzzi, S, Herukka, S-K, Santana, I, Baldeiras, I, de Mendonça, A, Silva, D, Chetelat, G, Egret, S, Palmqvist, S, Hansson, O, Visser, P J, Berkhof, J, van der Flier, W M & Alzheimer's Disease Neuroimaging Initiative 2019, 'Biomarker-based prognosis for people with mild cognitive impairment (ABIDE) : a modelling study', Lancet Neurology, vol. 18, no. 11, pp. 1034-1044. https://doi.org/10.1016/S1474-4422(19)30283-2
    The lancet / Neurology 18(11), 1034-1044 (2019). doi:10.1016/S1474-4422(19)30283-2
    The Lancet Neurology, Vol. 18, No 11 (2019) pp. 1034-1044

    Predmety: Male, statistics & numerical data [Multicenter Studies as Topic], epidemiology [Alzheimer Disease], pathology [Cognitive Dysfunction], PROGRESSION, cerebrospinal fluid [Amyloid beta-Peptides], Kaplan-Meier Estimate, Hippocampus, North America/epidemiology, 618.97, pathology [Alzheimer Disease], 0302 clinical medicine, Diagnosis, Multicenter Studies as Topic, Phosphorylation, Aged, 80 and over, Progression, Cognitive Dysfunction/cerebrospinal fluid/pathology, DEMENTIA, epidemiology [Europe], Organ Size, Csf biomarkers, Middle Aged, Prognosis, Magnetic Resonance Imaging, Alzheimer Disease/cerebrospinal fluid/epidemiology/pathology, 3. Good health, cerebrospinal fluid [Alzheimer Disease], cerebrospinal fluid [Cognitive Dysfunction], ALZHEIMERS-DISEASE, Europe, cerebrospinal fluid [Biomarkers], Disease Progression, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Female, Peptide Fragments/cerebrospinal fluid, epidemiology [North America], CSF BIOMARKERS, Neuroimaging, tau Proteins/cerebrospinal fluid/chemistry, DIAGNOSIS, Europe/epidemiology, Multicenter Studies as Topic/statistics & numerical data, 03 medical and health sciences, Alzheimer Disease, Hippocampus/pathology, Humans, Biomarkers/cerebrospinal fluid, Cognitive Dysfunction, [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], ddc:610, cerebrospinal fluid [Peptide Fragments], Proportional Hazards Models, Aged, Amyloid beta-Peptides, chemistry [tau Proteins], Amyloid beta-Peptides/cerebrospinal fluid, Alzheimers disease, pathology [Hippocampus], cerebrospinal fluid [tau Proteins], ddc:618.97, Nerve Degeneration, North America, Dementia, Protein Processing, Post-Translational, Biomarkers, Follow-Up Studies

    Popis súboru: application/pdf

  3. 3

    Prispievatelia: Klemen Dovc Charlotte Boughton Martin Tauschmann a ďalší

    Zdroj: APCam11 Consortium, AP@home Consortium & KidsAP Consortia 2019, 'Young Children Have Higher Variability of Insulin Requirements : Observations During Hybrid Closed-Loop Insulin Delivery', Diabetes Care, vol. 42, no. 7, pp. 1344-1347. https://doi.org/10.2337/dc18-2625
    Diabetes Care

    Popis súboru: application/vnd.openxmlformats-officedocument.wordprocessingml.document

  4. 4

    Zdroj: Paediatric Anaesthesia, Vol. 29, No 3 (2019) pp. 243-249

    Popis súboru: application/pdf

  5. 5

    Zdroj: Nielsen, L K, Abildgaard, N, Jarden, M & Klausen, T W 2019, ' Methodological aspects of health-related quality of life measurement and analysis in patients with multiple myeloma ', British Journal of Haematology, vol. 185, no. 1, pp. 11-24 . https://doi.org/10.1111/bjh.15759
    Kongsgaard Nielsen, L, Abildgaard, N, Jarden, M E & Klausen, T W 2019, ' Methodological aspects of health-related quality of life measurement and analysis in patients with multiple myeloma ', British Journal of Haematology, vol. 185, no. 1, pp. 11-24 . https://doi.org/10.1111/bjh.15759

    Popis súboru: application/pdf

  6. 6

    Autori: sattar NA Ginsberg H Ray K a ďalší

    Prispievatelia: sattar NA Ginsberg H Ray K a ďalší

    Zdroj: ATHEROSCLEROSIS SUPPLEMENTS
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
    instname
    Atherosclerosis Supplements
    Repositori Institucional de la Universitat Rovira i Virgili
    Consejo Superior de Investigaciones Científicas (CSIC)
    Universitat Rovira i virgili (URV)
    Sattar, N A, Ginsberg, H, Ray, K, Chapman, M J, Arca, M, Averna, M, Betteridge, D J, Bhatnagar, D, Bilianou, E, Carmena, R, Ceška, R, Corsini, A, Erbel, R, Flynn, P D, Garcia-Moll, X, Gumprecht, J, Ishibashi, S, Jambart, S, Kastelein, J J P, Maher, V, da Silva, P M, Masana, L, Odawara, M, Pedersen, T R, Rotella, C M, Salti, I, Teramoto, T, Tokgozoglu, L, Valensi, P & Vergès, B 2014, ' The use of statins in people at risk of developing diabetes mellitus : evidence and guidance for clinical practice ', Atherosclerosis. Supplements, vol. 15, no. 1, pp. 1-15 . https://doi.org/10.1016/j.atherosclerosissup.2014.04.001

    Predmety: Male, HSM MED, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Anticholesteremic Agents/adverse effects, Medizin, 1567-5688, Comorbidity, Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage, Cardiovascular, Fasting/blood, Cohort Studies, 0302 clinical medicine, Risk Factors, Anticholesteremic Agents/administration & dosage, Diabetes Mellitus, Type 2/prevention & control, Multicenter Studies as Topic, T2D, Diabetis, Anticholesteremic Agents, Diabetes, Hemoglobin A, Glycosylated/analysis, Hemoglobin A, Fasting, Diabetogenicity, Middle Aged, CVD, 3. Good health, Observational Studies as Topic, Cholesterol, Cholesterol, LDL/blood, Cardiovascular Diseases, Practice Guidelines as Topic, Disease Susceptibility, Cardiovascular Diseases/prevention & control, Type 2, Adult, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Anticholesteremic Agents/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology, Glycosylated, Diabetes Mellitus, Type 2/etiology, Risk Assessment, Multicenter Studies as Topic/statistics & numerical data, LDL, Prediabetic State, 03 medical and health sciences, Meta-Analysis as Topic, Diabetes Mellitus, Humans, Hemoglobin A, Glycosylated, Prediabetic State/epidemiology, Glycated Hemoglobin, Statins, Cardiovascular Diseases/epidemiology, statin, Cholesterol, LDL, Anticholesteremic Agents/pharmacology, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2, Estatines (Medicaments cardiovasculars), Hydroxymethylglutaryl-CoA Reductase Inhibitors, Observational Study as Topic, Forecasting

    Popis súboru: application/pdf

    Prístupová URL adresa: https://air.unimi.it/bitstream/2434/588539/2/1-s2.0-S1567568814000026-main.pdf
    https://pubmed.ncbi.nlm.nih.gov/24840509
    https://hdl.handle.net/2434/588539
    https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9276
    https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9276
    https://air.unimi.it/retrieve/handle/2434/588539/1083515/1-s2.0-S1567568814000026-main.pdf
    http://hdl.handle.net/20.500.11797/PC767
    https://hdl.handle.net/20.500.11797/PC767
    https://research.manchester.ac.uk/en/publications/c63b361d-4c32-4106-b040-9ddf6c964d7b
    https://doi.org/10.1016/j.atherosclerosissup.2014.04.001
    https://moh-it.pure.elsevier.com/en/publications/the-use-of-statins-in-people-at-risk-of-developing-diabetes-melli
    https://pubmed.ncbi.nlm.nih.gov/24840509/
    https://repositorio.chlc.min-saude.pt/bitstream/10400.17/2133/1/Atherosclerosis%20Sup%202014.pdf
    https://www.sciencedirect.com/science/article/abs/pii/S1567568814000026#!
    https://www.atherosclerosis-supplements.com/article/S1567-5688(14)00002-6/fulltext
    https://air.unimi.it/handle/2434/588539
    https://pure.amsterdamumc.nl/en/publications/184122fe-89e9-4b47-b538-7561ff63c92c
    https://doi.org/10.1016/j.atherosclerosissup.2014.04.001
    http://hdl.handle.net/10400.17/2133
    https://air.unimi.it/retrieve/handle/2434/588539/1083515/1-s2.0-S1567568814000026-main.pdf
    https://hdl.handle.net/20.500.11797/PC767
    https://hdl.handle.net/10447/94465
    https://doi.org/10.1016/j.atherosclerosissup.2014.04.001
    https://hdl.handle.net/11573/650630
    https://doi.org/10.1016/j.atherosclerosissup.2014.04.001
    https://hdl.handle.net/2158/958356
    https://www.ncbi.nlm.nih.gov/pubmed/24840509
    https://doi.org/10.1016/j.atherosclerosissup.2014.04.001

  7. 7

    Prispievatelia: Hyuk Jae Chang Namsik Chung Hyuk-Jae Chang a ďalší

    Zdroj: Circulation Journal. 75:246-252

    Popis súboru: 246~252

  8. 8

    Autori: Correa C McGale P Taylor C a ďalší

    Prispievatelia: Correa C McGale P Taylor C a ďalší

    Zdroj: Bundred, N, Correa, C, McGale, P, Taylor, C, Wang, Y, Clarke, M, Davies, C, Peto, R, Bijker, N, Solin, L & Darby, S 2010, 'Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast', Journal of the National Cancer Institute-Monographs, no. 41, pp. 162-177. https://doi.org/10.1093/jncimonographs/lgq039

    Predmety: Segmental, Review, Carcinoma, Intraductal, Noninfiltrating - drug therapy - radiotherapy - surgery, radioterapia, Mastectomy, Segmental, Noninfiltrating, 0302 clinical medicine, Second Primary -- epidemiology -- prevention & control, Neoplasms, Ductal, Noninfiltrating - drug therapy - radiotherapy - surgery, Multicenter Studies as Topic, Hormonal -- therapeutic use, Breast, Non-U.S. Gov't, Adjuvant, Mastectomy, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic - statistics and numerical data, Carcinoma, Ductal, Breast, Neoplasms, Second Primary, Middle Aged, Combined Modality Therapy, 3. Good health, Randomized Controlled Trials as Topic -- statistics & numerical data, Second Primary, Local, Chemotherapy, Adjuvant, oncology, Adjuvant -- statistics & numerical data, Female, Multicenter Studies as Topic -- statistics & numerical data, Noninfiltrating -- drug therapy -- radiotherapy -- surgery, Adult, Breast -- epidemiology -- prevention & control, DCIS, Antineoplastic Agents, Hormonal, Intraductal, Antineoplastic Agents, Breast Neoplasms, Tamoxifen -- therapeutic use, Research Support, 03 medical and health sciences, breast cancer, SDG 3 - Good Health and Well-being, Meta-Analysis as Topic, Breast Neoplasms -- drug therapy -- radiotherapy -- surgery, Radiotherapy, Adjuvant - statistics and numerical data, Journal Article, Chemotherapy, Humans, radiotherapy, Aged, clinical trials, Hormonal, Radiotherapy, Carcinoma, Adjuvant - statistics and numerical data, Cancérologie, Local -- epidemiology -- prevention & control, Tamoxifen, Neoplasm Recurrence, Carcinoma, Intraductal, Noninfiltrating, Radiotherapy, Adjuvant, Breast Neoplasms - drug therapy - radiotherapy - surgery, Multicenter Studies as Topic - statistics and numerical data, Neoplasm Recurrence, Local

    Popis súboru: STAMPA; 2 full-text file(s): application/pdf; application/pdf

    Prístupová URL adresa: https://academic.oup.com/jncimono/article-pdf/2010/41/162/2649509/lgq039.pdf
    https://pubmed.ncbi.nlm.nih.gov/20956824
    https://research.manchester.ac.uk/en/publications/e0dda2e8-0540-4223-83d5-5b4f6315a1ff
    https://doi.org/10.1093/jncimonographs/lgq039
    http://hdl.handle.net/11588/487315
    http://hdl.handle.net/11588/422119
    http://hdl.handle.net/11368/2502341
    https://cris.maastrichtuniversity.nl/en/publications/fa375491-0525-4e8a-a4a6-b59b8c468655
    https://doi.org/10.1093/jncimonographs/lgq039
    https://utsouthwestern.pure.elsevier.com/en/publications/overview-of-the-randomized-trials-of-radiotherapy-in-ductal-carci
    https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/118211/Details
    https://moh-it.pure.elsevier.com/en/publications/overview-of-the-randomized-trials-of-radiotherapy-in-ductal-carci
    https://researchonline.gcu.ac.uk/en/publications/overview-of-the-randomized-trials-of-radiotherapy-in-ductal-carci
    http://europepmc.org/articles/PMC5161078
    http://www.diva-portal.org/smash/record.jsf?pid=diva2:383069
    https://pure.amsterdamumc.nl/en/publications/00b2f79b-0dd8-4ae7-8c2e-72f9f7db5c7f
    https://doi.org/10.1093/jncimonographs/lgq039
    https://ora.ox.ac.uk/objects/uuid:a26ef862-793c-4137-915f-60ecb2ec226f
    https://doi.org/10.1093/jncimonographs/lgq039
    https://hdl.handle.net/11368/2502341
    https://doi.org/10.1093/jncimonographs/lgq039
    https://hdl.handle.net/11588/487315
    https://doi.org/10.1093/jncimonographs/lgq039
    https://hdl.handle.net/11588/422119
    http://hdl.handle.net/10722/139113

  9. 9

    Autori: Fung, J Yuen, MF But, DYK a ďalší

    Zdroj: Expert Opinion on Drug Safety. 9:821-829

  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Zdroj: Journal of the National Cancer Institute. Monographs, 2010 (41

    Popis súboru: 2 full-text file(s): application/pdf | application/pdf

    Relation: uri/info:doi/10.1093/jncimonographs/lgq039; uri/info:pii/lgq039; uri/info:pmid/20956824; https://dipot.ulb.ac.be/dspace/bitstream/2013/118211/3/lgq039.pdf; https://dipot.ulb.ac.be/dspace/bitstream/2013/118211/4/doi_99026.pdf

  19. 19